Q1 2022 Ajanta Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Ajanta Pharma Limited Q1 FY22 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Yogesh Agarwal, Managing Director of Ajanta Pharma Limited. Thank you, and over to you sir.
Thank you. Good evening, and welcome, everyone. With me, I have Mr. Rajesh Agarwal, our Joint Managing Director, and Mr. Arvind Agrawal, our CFO. So before we move on to the business our thoughts and prayers are with everyone who suffered the effects of the second wave of COVID and especially to those who have lost their loved ones.
Recognizing that vaccination was our best back to an early return to the normalcy. We started the vaccination drive across all our locations starting in March. This covered not only Ajantaites but also their family members and I'm happy to say that over 88% of our Ajantaites have been vaccinated with at least one shot. As we speak national vaccination program is also progressing
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |